ArticleInternational journal of hematology-oncology and stem cell research2025
Hybrid Ganciclovir/Valacyclovir Prophylaxis Reduces CMV Reactivation in High-Risk Allogeneic Stem Cell Transplant Recipients.
Maryam Barkhordar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.